Abbott Laboratories (ABT) Current Assets (2009 - 2026)

Abbott Laboratories has disclosed Current Assets across 18 years of filings, most recently posting $24.5 billion for Q2 2026.

• In Q2 2026, Current Assets changed 0.2% year-over-year to $24.5 billion; the TTM figure through Jun 2026 stood at $24.5 billion (changed 0.2% YoY), while the FY2025 annual figure was $26.0 billion, up 9.89% from the prior year.
• Current Assets came in at $24.5 billion for Q2 2026 at Abbott Laboratories, down from $25.5 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $26.0 billion in Q4 2025 to a low of $22.4 billion in Q1 2024.
• Average Current Assets over 5 years is $24.1 billion, with a median of $24.1 billion recorded in 2023.
• Year-over-year, Current Assets grew 10.29% in 2022 and retreated 10.13% in 2023.
• Over 5 years, Current Assets stood at $25.2 billion in 2022, then dropped by 10.13% to $22.7 billion in 2023, then climbed by 4.35% to $23.7 billion in 2024, then increased by 9.89% to $26.0 billion in 2025, then dropped by 5.69% to $24.5 billion in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $24.5 billion in Q2 2026, $25.5 billion in Q1 2026, and $26.0 billion in Q4 2025.